|
1
|
WHO/ICO Information Centre on HPV and
Cervical Cancer. Human papillomavirus and related cancers in
Brazil. Summary Report. 2010, (cited May 12, 2010). Available from:
www.who.int/hpvcentrehttps://www.who.int/hpvcentre.
|
|
2
|
Walboomers JM, Jacobs MV, Manos MM, Bosch
FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ganguly N and Parihar SP: Human
papillomavirus E6 and E7 oncoproteins as risk factors for
tumorigenesis. J Biosci. 34:113–123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moody CA and Laimins LA: Human
papillomavirus oncoproteins: Pathways to transformation. Nat Rev
Cancer. 10:550–560. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kern SE, Kinzler KW, Bruskin A, Jarosz D,
Friedman P, Prives C and Vogelstein B: Identification of p53 as a
sequence-specific DNA-binding protein. Science. 252:1708–1711.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vogelstein B, Lane D and Levine AJ:
Surfing the p53 network. Nature. 408:307–310. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Akeno N, Miller AL, Ma X and
Wikenheiser-Brokamp KA: p53 suppresses carcinoma progression by
inhibiting mTOR pathway activation. Oncogene. 34:589–599. 2015.
View Article : Google Scholar
|
|
8
|
Karakoula K, Jacques TS, Phipps KP,
Harkness W, Thompson D, Harding BN, Darling JL and Warr TJ:
Epigenetic genome-wide analysis identifies BEX1 as a candidate
tumour suppressor gene in paediatric intracranial ependymoma.
Cancer Lett. 346:34–44. 2014. View Article : Google Scholar
|
|
9
|
Christoph F, Kempkensteffen C, Weikert S,
Krause H, Schostak M, Miller K and Schrader M: Frequent epigenetic
inactivation of p53 target genes in seminomatous and
nonseminomatous germ cell tumors. Cancer Lett. 247:137–142. 2007.
View Article : Google Scholar
|
|
10
|
Suzuki H, Itoh F, Toyota M, Kikuchi T,
Kakiuchi H and Imai K: Inactivation of the 14-3-3 sigma gene is
associated with 5′ CpG island hypermethylation in human cancers.
Cancer Res. 60:4353–4357. 2000.PubMed/NCBI
|
|
11
|
Sova P, Feng Q, Geiss G, Wood T, Strauss
R, Rudolf V, Lieber A and Kiviat N: Discovery of novel methylation
biomarkers in cervical carcinoma by global demethylation and
microarray analysis. Cancer Epidemiol Biomarkers Prev. 15:114–123.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Banzai C, Nishino K, Quan J, Yoshihara K,
Sekine M, Yahata T and Tanaka K: Gynecological Cancer Registry of
Niigata: Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A
genes in cervical carcinoma. Int J Clin Oncol. 19:127–132. 2014.
View Article : Google Scholar
|
|
13
|
Portela A and Esteller M: Epigenetic
modifications and human disease. Nat Biotechnol. 28:1057–1068.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Esteller M: Cancer epigenomics: DNA
methylomes and histone-modification maps. Nat Rev Genet. 8:286–298.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bierkens M, Hesselink AT, Meijer CJ,
Heideman DA, Wisman GB, van der Zee AG, Snijders PJ and Steenbergen
RD: CADM1 and MAL promoter methylation levels in hrHPV-positive
cervical scrapes increase proportional to degree and duration of
underlying cervical disease. Int J Cancer. 133:1293–1299. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kuramochi M, Fukuhara H, Nobukuni T, Kanbe
T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura
T, et al: TSLC1 is a tumor-suppressor gene in human non-small-cell
lung cancer. Nat Genet. 27:427–430. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Murakami Y: Involvement of a cell adhesion
molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci.
96:543–552. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Steenbergen RD, Kramer D, Braakhuis BJ,
Stern PL, Verheijen RH, Meijer CJ and Snijders PJ: TSLC1 gene
silencing in cervical cancer cell lines and cervical neoplasia. J
Natl Cancer Inst. 96:294–305. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Overmeer RM, Henken FE, Snijders PJ,
Claassen-Kramer D, Berkhof J, Helmerhorst TJ, Heideman DA, Wilting
SM, Murakami Y, Ito A, et al: Association between dense CADM1
promoter methylation and reduced protein expression in high-grade
CIN and cervical SCC. J Pathol. 215:388–397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang WS, Park SO, Yoon AR, Yoo JY, Kim MK,
Yun CO and Kim CW: Suicide cancer gene therapy using pore-forming
toxin, streptolysin O. Mol Cancer Ther. 5:1610–1619. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karpf AR, Moore BC, Ririe TO and Jones DA:
Activation of the p53 DNA damage response pathway after inhibition
of DNA methyltransferase by 5-aza-2′-deoxycytidine. Mol Pharmacol.
59:751–757. 2001.PubMed/NCBI
|
|
22
|
Yoon CH, Rho SB, Kim ST, Kho S, Park J,
Jang IS, Woo S, Kim SS, Lee JH and Lee SH: Crucial role of TSC-22
in preventing the proteasomal degradation of p53 in cervical
cancer. PLoS One. 7:e420062012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fukuhara H, Kuramochi M, Fukami T,
Kasahara K, Furuhata M, Nobukuni T, Maruyama T, Isogai K, Sekiya T,
Shuin T, et al: Promoter methylation of TSLC1 and tumor suppression
by its gene product in human prostate cancer. Jpn J Cancer Res.
93:605–609. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ito T, Shimada Y, Hashimoto Y, Kaganoi J,
Kan T, Watanabe G, Murakami Y and Imamura M: Involvement of TSLC1
in progression of esophageal squamous cell carcinoma. Cancer Res.
63:6320–6326. 2003.PubMed/NCBI
|
|
25
|
Lung HL, Cheung AK, Xie D, Cheng Y, Kwong
FM, Murakami Y, Guan XY, Sham JS, Chua D, Protopopov AI, et al:
TSLC1 is a tumor suppressor gene associated with metastasis in
nasopharyngeal carcinoma. Cancer Res. 66:9385–9392. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mao X, Seidlitz E, Truant R, Hitt M and
Ghosh HP: Re-expression of TSLC1 in a non-small-cell lung cancer
cell line induces apoptosis and inhibits tumor growth. Oncogene.
23:5632–5642. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liang QL, Wang BR, Li ZY, Chen GQ and Zhou
Y: Effect of TSLC1 gene on growth and apoptosis in human esophageal
carcinoma Eca109 cells. Arch Med Sci. 8:987–992. 2012. View Article : Google Scholar
|
|
28
|
Qin L, Zhu W, Xu T, Hao Y, Zhang Z, Tian Y
and Yang D: Effect of TSLC1 gene on proliferation, invasion and
apoptosis of human hepatocellular carcinoma cell line HepG2. J
Huazhong Univ Sci Technolog Med Sci. 27:535–537. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shingai T, Ikeda W, Kakunaga S, Morimoto
K, Takekuni K, Itoh S, Satoh K, Takeuchi M, Imai T, Monden M, et
al: Implications of nectin-like
molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion
and transmembrane protein localization in epithelial cells. J Biol
Chem. 278:35421–35427. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Murakami Y, Nobukuni T, Tamura K, Maruyama
T, Sekiya T, Arai Y, Gomyou H, Tanigami A, Ohki M, Cabin D, et al:
Localization of tumor suppressor activity important in nonsmall
cell lung carcinoma on chromosome 11q. Proc Natl Acad Sci USA.
95:8153–8158. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Al-Shabanah OA, Hafez MM, Hassan ZK,
Sayed-Ahmed MM, Abozeed WN, Alsheikh A and Al-Rejaie SS:
Methylation of SFRPs and APC genes in ovarian cancer infected with
high risk human papillomavirus. Asian Pac J Cancer Prev.
15:2719–2725. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Leonard SM, Wei W, Collins SI, Pereira M,
Diyaf A, Constandinou-Williams C, Young LS, Roberts S and Woodman
CB: Oncogenic human papillomavirus imposes an instructive pattern
of DNA methylation changes which parallel the natural history of
cervical HPV infection in young women. Carcinogenesis.
33:1286–1293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pritchard DM, Watson AJ, Potten CS,
Jackman AL and Hickman JA: Inhibition by uridine but not thymidine
of p53-dependent intestinal apoptosis initiated by 5-fluorouracil:
Evidence for the involvement of RNA perturbation. Proc Natl Acad
Sci USA. 94:1795–1799. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shames DS, Minna JD and Gazdar AF: DNA
methylation in health, disease, and cancer. Curr Mol Med. 7:85–102.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Longley DB, Harkin DP and Johnston PG:
5-fluorouracil: Mechanisms of action and clinical strategies. Nat
Rev Cancer. 3:330–338. 2003. View
Article : Google Scholar : PubMed/NCBI
|
